Mode of Action, Clinical Profile and Significance of Beta-Blockers in Antiglaucoma Therapy

被引：3
|
作者：
Schlote, T. [1 ]
机构：
[1] Tagesklin Ambimed, CH-4057 Basel, Switzerland
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2013年 / 230卷 / 02期
关键词：
glaucoma; pharmacology; biochemistry; DIURNAL INTRAOCULAR-PRESSURE; TIMOLOL MALEATE; UNFIXED COMBINATION; FIXED COMBINATION; GLAUCOMA PATIENTS; EFFICACY; TOLERABILITY; METAANALYSIS; EXFOLIATION; SAFETY;
D O I：
10.1055/s-0032-1327784
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Beta-blockers are among the most important groups of drugs for glaucoma therapy. The advantages of beta-blockers are a good efficacy in primary and secondary types of glaucoma, different dosages, clinical experiences over decades, easy use in combination with all other glaucoma drugs, and low costs. Timolol is the most frequently used drug in fixed glaucoma medications. In comparison with other glaucoma drugs, beta-blockers have the most severe systemic side effects and may interact with other systemic medication.
引用
收藏
页码：120 / 126
页数：7
相关论文
共 50 条
  • [21] EFFECT OF BETA-BLOCKERS ON BLOOD LIPID PROFILE
    LEHTONEN, A
    AMERICAN HEART JOURNAL, 1985, 109 (05) : 1192 - 1196
  • [22] Beta-Blockers as Therapy for Infantile Hemangiomas
    Nguyen, Harrison P.
    Pickrell, Brent B.
    Wright, Teresa S.
    SEMINARS IN PLASTIC SURGERY, 2014, 28 (02) : 87 - 90
  • [23] Therapy of heart failure with beta-blockers
    Laufs, U
    Erdmann, E
    HERZ KREISLAUF, 1999, 31 (09): : 363 - 366
  • [24] A myth of ophthalmic beta-blockers therapy
    Weekitt Kittisupamongkol
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1721 - 1721
  • [25] Beta-blockers and Ambulatory Inotropic Therapy
    Zaghlol, Raja
    Ghazzal, Amre
    Radwan, Sohab
    Zaghlol, Louay
    Hamad, Ahmad
    Chou, Jiling
    Ahmed, Sara
    Hofmeyer, Mark
    Rodrigo, Maria E.
    Kadakkal, Ajay
    Lam, Phillip H.
    Rao, Sriram D.
    Weintraub, William S.
    Molina, Ezequiel J.
    Sheikh, Farooq H.
    Najjar, Samer S.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (08) : 1309 - 1317
  • [26] Antihypertensive differential therapy with beta-blockers
    Scholze, J
    HERZ KREISLAUF, 1998, 30 (02): : 47 - 55
  • [27] Topical beta-blockers in dermatologic therapy
    Filoni, Angela
    Ambrogio, Francesca
    De Marco, Aurora
    Pacifico, Alessia
    Bonamonte, Domenico
    DERMATOLOGIC THERAPY, 2021, 34 (04)
  • [28] CLINICAL ASPECTS OF BETA-BLOCKERS IN HYPERTENSION
    STUMPE, KO
    OVERLACK, A
    KOLLOCH, R
    CARDIOLOGY, 1980, 66 : 36 - 46
  • [29] A myth of ophthalmic beta-blockers therapy
    Kittisupamongkol, Weekitt
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (12) : 1721 - 1721
  • [30] Beta-blockers in Cardiovascular Therapy: A Review
    Diaconu, Camelia C.
    Marcu, Dragos R.
    Bratu, Ovidiu G.
    Stanescu, Ana Maria A.
    Gheorghe, Gina
    Hlescu, Andreea A.
    Mischianu, Dan L. D.
    Manea, Maria
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2019, 6 (02): : 216 - 223
12345